Literature DB >> 2553242

Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma.

M F Chen1, Y Y Jan, C S Wang, L B Jeng, T L Hwang.   

Abstract

During the 10-year period from 1978 to 1987, hepatic resections were performed on 20 patients with peripheral cholangiocarcinoma (PCC). Nine of these patients were men and 11 were women (mean age, 48.5 years). Among them, 80% had intrahepatic stones with recurrent cholangitis. The 20 patients were subdivided into the following three groups: Group I (12 patients with surgery for PCC); Group II (4 patients with surgery for chronic cholangitis [but the final pathologic diagnosis confirmed PCC]); and Group III (4 patients with surgery for space-occupying liver lesions). No early postoperative mortality was noticed. The few complications that occurred were related to surgery for hepatolithiasis. Postoperative wound infection was the most common complication. The overall mean survival time was 20.5 months. Four patients survived for more than 3 years; one was even alive for more than 5 years after surgery.

Entities:  

Mesh:

Year:  1989        PMID: 2553242     DOI: 10.1002/1097-0142(19891201)64:11<2226::aid-cncr2820641107>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Prognostic factors in hilar cholangiocarcinoma.

Authors:  M Sahin
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

2.  Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma.

Authors:  T Uenishi; K Hirohashi; S Kubo; T Yamamoto; H Hamba; H Tanaka; H Kinoshita
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

3.  Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases.

Authors:  J R Madariaga; S Iwatsuki; S Todo; R G Lee; W Irish; T E Starzl
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

4.  Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases.

Authors:  M F Chen; Y Y Jan; T C Chen
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

5.  Hepatic resection and transplantation for peripheral cholangiocarcinoma.

Authors:  F A Casavilla; J W Marsh; S Iwatsuki; S Todo; R G Lee; J R Madariaga; A Pinna; I Dvorchik; J J Fung; T E Starzl
Journal:  J Am Coll Surg       Date:  1997-11       Impact factor: 6.113

6.  Intrahepatic stones. The transhepatic team approach.

Authors:  H A Pitt; A C Venbrux; J Coleman; C A Prescott; M S Johnson; F A Osterman; J L Cameron
Journal:  Ann Surg       Date:  1994-05       Impact factor: 12.969

7.  Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma.

Authors:  Xin-Da Zhou; Zhao-You Tang; Jia Fan; Jian Zhou; Zhi-Quan Wu; Lun-Xiu Qin; Zeng-Chen Ma; Hui-Chuan Sun; Shuang-Jian Qiu; Yao Yu; Ning Ren; Qing-Hai Ye; Lu Wang; Sheng-Long Ye
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-18       Impact factor: 4.553

8.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

9.  Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma.

Authors:  Shohachi Suzuki; Takanori Sakaguchi; Yoshihiro Yokoi; Kazuya Okamoto; Kiyotaka Kurachi; Yasuo Tsuchiya; Takuya Okumura; Hiroyuki Konno; Satoshi Baba; Satoshi Nakamura
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352

10.  Surgical treatment of cholangiocellular carcinoma.

Authors:  R Pichlmayr; P Lamesch; A Weimann; G Tusch; B Ringe
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.